KEVIN RAKIN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KEVIN RAKIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN RAKIN. KEVIN RAKIN is Pres. and CEO in GENAISSANCE PHARMACEUTICALS INC ($GNSC) and President & CEO in GENAISSANCE PHARMACEUTICALS INC ($GNSC) and Director in ORAMED PHARMACEUTICALS INC. ($IGVL) and Director in HISTOGENICS CORP ($HSGX).
Latest Insider Trading Transactions of KEVIN RAKIN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GNSC, HSGX, ORMP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2021 | ORMP | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | A | 11.33 | 15,000 | 169,950 | 15,000 | |
| Jan 14 2020 | ORMP | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | A | 4.80 | 20,000 | 96,000 | 20,000 | |
| Sep 16 2019 | ORMP | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | A | 4.17 | 10,000 | 41,700 | 10,000 | |
| Sep 16 2019 | ORMP | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | D | 4.17 | 10,000 | 41,700 | 0 | |
| Apr 12 2019 | ORMP | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | A | 4.17 | 10,000 | 41,700 | 10,000 | |
| Feb 11 2019 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | M | 0.01 | 111,111 | 1,111 | 0 | |
| Feb 11 2019 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | M | 0.01 | 33,333 | 333 | 0 | |
| Feb 11 2019 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | M | 0.01 | 33,333 | 333 | 0 | |
| Feb 11 2019 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | M | 0.01 | 173,076 | 1,731 | 0 | |
| Feb 11 2019 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Buy | M | 0.00 | 111,111 | 0 | 257,846 | 146.7 K to 257.8 K (+75.72 %) |
| Feb 11 2019 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Buy | M | 0.00 | 33,333 | 0 | 66,666 | 33.3 K to 66.7 K (+100.00 %) |
| Feb 11 2019 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Buy | M | 0.00 | 33,333 | 0 | 66,666 | 33.3 K to 66.7 K (+100.00 %) |
| Feb 11 2019 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Buy | M | 0.00 | 173,076 | 0 | 418,639 | 245.6 K to 418.6 K (+70.48 %) |
| Oct 11 2018 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | P | 0.70 | 173,076 | 121,153 | 173,076 | |
| Oct 11 2018 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Buy | P | 0.00 | 230,768 | 0 | 245,563 | 14.8 K to 245.6 K (+1,559.77 %) |
| Jun 19 2018 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 2.97 | 25,000 | 74,250 | 25,000 | |
| Jul 05 2017 | IGVL | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | A | 7.77 | 56,773 | 441,126 | 56,773 | |
| Jun 14 2017 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 1.70 | 25,000 | 42,500 | 25,000 | |
| Feb 16 2017 | IGVL | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | A | 6.23 | 5,697 | 35,492 | 5,697 | |
| Dec 19 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 1.58 | 10,000 | 15,800 | 10,000 | |
| Dec 07 2016 | IGVL | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Grant | A | 6.59 | 3,300 | 21,763 | 15,061 | 11.8 K to 15.1 K (+28.06 %) |
| Dec 07 2016 | IGVL | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Grant | A | 6.38 | 2,300 | 14,665 | 11,761 | 9.5 K to 11.8 K (+24.31 %) |
| Dec 05 2016 | IGVL | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Grant | A | 6.21 | 7,261 | 45,057 | 9,461 | 2.2 K to 9.5 K (+330.05 %) |
| Dec 05 2016 | IGVL | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Grant | A | 6.08 | 2,200 | 13,371 | 2,200 | 0 to 2.2 K |
| Dec 02 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | C | 0.00 | 200 | 0 | 0 | |
| Dec 02 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | C | 0.00 | 60 | 0 | 0 | |
| Dec 02 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | C | 0.00 | 60 | 0 | 0 | |
| Dec 02 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Buy | C | 0.00 | 88,998 | 0 | 228,196 | 139.2 K to 228.2 K (+63.94 %) |
| Dec 02 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Buy | C | 0.00 | 26,699 | 0 | 139,198 | 112.5 K to 139.2 K (+23.73 %) |
| Dec 02 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Buy | C | 0.00 | 26,699 | 0 | 112,499 | 85.8 K to 112.5 K (+31.12 %) |
| Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 2.25 | 111,111 | 250,000 | 177,777 | |
| Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 2.25 | 33,333 | 74,999 | 66,666 | |
| Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 2.25 | 33,333 | 74,999 | 33,333 | |
| Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 0.00 | 200 | 0 | 320 | |
| Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 0.00 | 60 | 0 | 120 | |
| Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 0.00 | 60 | 0 | 60 | |
| Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Grant | A | 2.25 | 22,113 | 49,754 | 85,800 | 63.7 K to 85.8 K (+34.72 %) |
| Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Grant | A | 2.25 | 6,634 | 14,927 | 63,687 | 57.1 K to 63.7 K (+11.63 %) |
| Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Grant | A | 2.25 | 6,634 | 14,927 | 57,053 | 50.4 K to 57.1 K (+13.16 %) |
| Jun 26 2015 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 6.86 | 20,000 | 137,200 | 20,000 | |
| Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Option Exercise | D | 2.20 | 135,000 | 297,000 | 0 | |
| Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Option Exercise | D | 3.74 | 60,000 | 224,400 | 0 | |
| Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Option Exercise | D | 2.56 | 140,000 | 358,400 | 0 | |
| Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Option Exercise | D | 0.85 | 75,000 | 63,750 | 0 | |
| Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Option Exercise | D | 5.00 | 50,000 | 250,000 | 0 | |
| Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Option Exercise | D | 2.50 | 50,000 | 125,000 | 0 | |
| Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Option Exercise | D | 3.80 | 100,000 | 380,000 | 0 | |
| Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Option Exercise | D | 12.00 | 400,000 | 4,800,000 | 0 | |
| Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Sell | D | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
| Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Sell | D | 0.00 | 95,000 | 0 | 0 | 95 K to 0 (-100.00 %) |
| Oct 06 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | President & CEO | Sell | D | 0.00 | 584,094 | 0 | 0 | 584.1 K to 0 (-100.00 %) |
| Jan 21 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | Pres. and CEO | Option Exercise | A | 2.20 | 135,000 | 297,000 | 135,000 | |
| Jan 21 2005 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | Pres. and CEO | Grant | A | 0.00 | 35,000 | 35 | 617,094 | 582.1 K to 617.1 K (+6.01 %) |
| Apr 29 2004 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | Pres. and CEO | Option Exercise | A | 3.74 | 60,000 | 224,400 | 60,000 | |
| Apr 29 2004 | GNSC | GENAISSANCE PHARMA ... | RAKIN KEVIN | Pres. and CEO | Gift | G | 0.00 | 2,500 | 0 | 582,094 | 584.6 K to 582.1 K (-0.43 %) |
Page: 1